重庆医学
重慶醫學
중경의학
CHONGQING MEDICAL JOURNAL
2015年
3期
353-355
,共3页
卵巢肿瘤%基质金属蛋白酶类%遗传多态性%M eta分析
卵巢腫瘤%基質金屬蛋白酶類%遺傳多態性%M eta分析
란소종류%기질금속단백매류%유전다태성%M eta분석
ovarian neoplasms%matrix metalloproteinases%genetic polymorphism%Meta-analysis
目的:应用Meta分析研究基质金属蛋白酶(MMP)‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A启动子基因多态性与卵巢癌易感性的关系。方法检索数据库中符合纳入MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A启动子基因多态性与卵巢癌易感性关系的病例对照研究,基因多态性与易感性的关系用比值比(OR)及95%可信区间(CI)表示,应用RevMan5.0对数据进行分析。结果共纳入8项研究,涉及MMP‐1的5项,MMP‐3的3项。Meta分析发现,MMP‐1‐1607bp1G/2G在1G/1G∶1G/2G+2G/2G模型下OR(95%CI)=0.95(0.74~1.21),P=0.67,1G/1G∶2G/2G模型下OR(95%CI)=0.93(0.70~1.23),P=0.60,1G∶2G模型下OR(95%CI)=0.99(0.87~1.14),P=0.91,MMP‐3‐1171bp5A/6A在5A/5A+5A/6A∶6A/6A模型下OR(95%CI)=0.97(0.68~1.38),P=0.85,差异无有统计学意义。结论目前的文献尚不能证实MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A启动子基因多态性与卵巢癌易感性有关。
目的:應用Meta分析研究基質金屬蛋白酶(MMP)‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A啟動子基因多態性與卵巢癌易感性的關繫。方法檢索數據庫中符閤納入MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A啟動子基因多態性與卵巢癌易感性關繫的病例對照研究,基因多態性與易感性的關繫用比值比(OR)及95%可信區間(CI)錶示,應用RevMan5.0對數據進行分析。結果共納入8項研究,涉及MMP‐1的5項,MMP‐3的3項。Meta分析髮現,MMP‐1‐1607bp1G/2G在1G/1G∶1G/2G+2G/2G模型下OR(95%CI)=0.95(0.74~1.21),P=0.67,1G/1G∶2G/2G模型下OR(95%CI)=0.93(0.70~1.23),P=0.60,1G∶2G模型下OR(95%CI)=0.99(0.87~1.14),P=0.91,MMP‐3‐1171bp5A/6A在5A/5A+5A/6A∶6A/6A模型下OR(95%CI)=0.97(0.68~1.38),P=0.85,差異無有統計學意義。結論目前的文獻尚不能證實MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A啟動子基因多態性與卵巢癌易感性有關。
목적:응용Meta분석연구기질금속단백매(MMP)‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A계동자기인다태성여란소암역감성적관계。방법검색수거고중부합납입MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A계동자기인다태성여란소암역감성관계적병례대조연구,기인다태성여역감성적관계용비치비(OR)급95%가신구간(CI)표시,응용RevMan5.0대수거진행분석。결과공납입8항연구,섭급MMP‐1적5항,MMP‐3적3항。Meta분석발현,MMP‐1‐1607bp1G/2G재1G/1G∶1G/2G+2G/2G모형하OR(95%CI)=0.95(0.74~1.21),P=0.67,1G/1G∶2G/2G모형하OR(95%CI)=0.93(0.70~1.23),P=0.60,1G∶2G모형하OR(95%CI)=0.99(0.87~1.14),P=0.91,MMP‐3‐1171bp5A/6A재5A/5A+5A/6A∶6A/6A모형하OR(95%CI)=0.97(0.68~1.38),P=0.85,차이무유통계학의의。결론목전적문헌상불능증실MMP‐1‐1607bp1G/2G、MMP‐3‐1171bp5A/6A계동자기인다태성여란소암역감성유관。
Objective To evaluate the association between matrix metalloproteinase‐1 (MMP‐1)‐1 607 bp 1G/2G and matrix metalloproteinase‐3(MMP‐3)‐1 171 bp 5A/6A polymorphisms in promoter regions and susceptibility to ovarian cancer by Meta‐a‐nalysis .Methods Case‐control studies with regards of relationship between MMP‐1‐1 607 bp 1G/2G ,MMP‐3‐1 171 bp 5A/6A pol‐ymorphisms in promoter regions and susceptibility to ovarian cancer were searched in electronic databases .Odds ratio (OR) and 95% confidence interval (CI) were used to evaluate the association between polymorphisms and susceptibility .RevMan5 .0 software was applied for data analysis .Results Eight studies ,containing 5 studies for MMP‐1 and 3 studies for MMP‐3 ,were selected .For MMP‐1‐1 607 bp 1G/2G ,OR(95% CI)=0 .95 (0 .74-1 .21) ,P=0 .67 under 1G/1G :1G/2G+2G/2G model ,OR(95% CI)=0 .93 (0 .70-1 .23) ,P=0 .60 under 1G/1G :2G/2G model ,OR(95% CI)=0 .99 (0 .87-1 .14) ,P=0 .91 under 1G :2G model;for MMP‐3‐1 171 bp 5A/6A ,OR(95% CI)=0 .97(0 .68-1 .38) ,P=0 .85 under 5A/5A+5A/6A :6A/6A model .Overall ,there was statisti‐cal significance .Conclusion It is still not confirmed that significant association between the MMP‐1‐1 607 bp 1G/2G and MMP‐3‐1 171 bp 5A/6A polymorphisms in promoter regions and susceptibility to ovarian cancer exists in current literature .